1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. Switzerland >
  6. NBE-Therapeutics AG

NBE-Therapeutics AG Overview

Life ScienceCompany

Where is NBE-Therapeutics AG headquartered?

NBE-Therapeutics AG is headquartered in Basel, Switzerland.

What sector is NBE-Therapeutics AG in?

NBE-Therapeutics AG is a life science company.

When was NBE-Therapeutics AG founded?

NBE-Therapeutics AG was founded in 2012.

NBE-Therapeutics AG

Technology Park Basel, Hochbergstrasse 60C,
Basel, CH-4057
Switzerland,
+41 61 633 22 30
www.nbe-therapeutics.com

NBE-Therapeutics is a privately-owned Swiss biotech company based in Basel and founded in 2012 with the vision of developing next-generation immune-stimulatory antibody-drug conjugate (iADC) products. NBE-Therapeutics advances its products to clinical proof of concept with the goal of improving treatment options for cancer patients. The company leverages proprietary platforms covering all aspects of ADC development: its Transpo-mAb Display technology for antibody discovery, its SMAC-Technology for site-specific payload conjugation of toxins to antibodies, and a novel highly effective and immune-stimulatory anthracycline-based toxin platform.


Company Summary

SECTOR

Life Science

Established

2012


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for NBE-Therapeutics AG

Life Science Companies , Switzerland Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Switzerland Companies

Largest Switzerland Companies , Acquisitive Switzerland Companies , Recently Acquired Switzerland Companies , Recently Sold Switzerland Companies , Private Switzerland Companies , Public Switzerland Companies , Acquired Switzerland Companies , PE Backed Switzerland Companies
Mergr

Solution for

Product

Company

Legal